Chronic Kidney Disease is a global problem

Between 8 and 10% of the adult population have some form of kidney damage, and every year millions die prematurely of complications related to Chronic Kidney Diseases (CKD). When it reaches End Stage (ESRD) the patient requires Dialysis. Despite the association of Peritoneal Dialysis with better patient cognitive and functional outcomes, most patients still undergo hemodialysis in special clinics.

A disruptive change in Peritoneal Dialysis (PD) technology is needed to give doctors confidence to prescribe safe self-treatment at the comfort of the home, for patients to widely adopt it and for clinics to offer it and thrive.

Introducing liberDi

More than just a medical device, liberDi is an innovative all-in-one portable dialysis system providing scalable, digital and safe, self-care anywhere. It provides remote medical supervision, replacing the need for full-service, in-clinic dialysis care.

liberDi’s system is positioned to replace traditional full-service, in-clinic care with a self-care system suitable for many dialysis patients. Focused on patient care liberation and improved quality of life, liberDi allows many more people requiring dialysis to do so easily and comfortably from wherever they are, be that their home, office or on vacation.

Founded in 2014 and supported by a team of world-renowned scientists, engineers and physicians, liberDi’s vision and mission have always been to find a way to free dialysis patients from the need to spend half their lives dialyzing in expensive dialysis clinics and centers.

liberDi’s cutting-edge innovation is safe, patient friendly, and portable. In addition to liberating patients, it also enables clinics to optimize their economic model and improve the quality of their service while lowering costs; This creates the optimal, world’s first, 360° platform for Renal patients and caregivers alike.